The purpose of this study is to determine whether long-term RPC1063 is safe and effective in the treatment of ulcerative colitis (UC)

Brief summary (registry, in English)

1. To evaluate the long-term safety and efficacy of RPC1063 for the treatment of all patients with moderate to severe UC 2. To evaluate the long-term efficacy of RPC1063 for the treatment of adult patients with moderate to severe UC.

What you commit to

• Study type: Interventional · Phase 3
• Participants enrolled: 223
• 24 sites in 7 countries
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Who cannot take part

Copied verbatim from EU CTIS (euclinicaltrials.eu) and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers

Full criteria on EU CTIS (euclinicaltrials.eu)

Sites (52)

Sites in registry order. Pick your city on the disease page to sort them by distance.